Xencor Inc (XNCR) stock
XNCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30194% above fair value
$34.50−0.90 (-2.54%)
Close on Nov 17, 2026Market cap $2.57BP/E –Yield –
Xencor ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Xencor's ebitda for the twelve months ending Jun 30, 2026 was -$206.23M. For fiscal 2025 it was -$166.99M. The highest annual figure on record is $51.26M in fiscal 2021.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$166.99M | – |
| FY2024 | Dec 31, 2024 | -$166.30M | – |
| FY2023 | Dec 31, 2023 | -$120.86M | – |
| FY2022 | Dec 31, 2022 | -$73.67M | -243.7% |
| FY2021 | Dec 31, 2021 | $51.26M | – |
| FY2020 | Dec 31, 2020 | -$71.00M | -491.8% |
| FY2019 | Dec 31, 2019 | $18.12M | – |
| FY2018 | Dec 31, 2018 | -$76.12M | – |
| FY2017 | Dec 31, 2017 | -$41.09M | -190.3% |
| FY2016 | Dec 31, 2016 | $45.51M | – |
| FY2015 | Dec 31, 2015 | -$17.23M | – |
| FY2014 | Dec 31, 2014 | -$15.58M | – |
| FY2013 | Dec 31, 2013 | -$9.81M | – |
| FY2012 | Dec 31, 2012 | -$5.70M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$34.77M | – |
| Q1 FY2026 | Mar 31, 2026 | -$75.30M | – |
| Q4 FY2025 | Dec 31, 2025 | -$51.05M | – |
| Q3 FY2025 | Sep 30, 2025 | -$45.12M | – |
| Q2 FY2025 | Jun 30, 2025 | -$30.77M | – |
| Q1 FY2025 | Mar 31, 2025 | -$40.49M | – |
| Q4 FY2024 | Dec 31, 2024 | -$10.18M | – |
| Q3 FY2024 | Sep 30, 2024 | -$52.40M | – |
| Q2 FY2024 | Jun 30, 2024 | -$52.67M | – |
| Q1 FY2024 | Mar 31, 2024 | -$51.63M | – |
| Q4 FY2023 | Dec 31, 2023 | -$24.12M | – |
| Q3 FY2023 | Sep 30, 2023 | -$15.13M | – |
| Q2 FY2023 | Jun 30, 2023 | -$23.11M | – |
| Q1 FY2023 | Mar 31, 2023 | -$58.50M | -304.2% |
| Q4 FY2022 | Dec 31, 2022 | -$40.43M | -143.1% |
| Q3 FY2022 | Sep 30, 2022 | -$36.11M | – |
| Q2 FY2022 | Jun 30, 2022 | -$25.78M | -337.8% |
| Q1 FY2022 | Mar 31, 2022 | $28.64M | – |
| Q4 FY2021 | Dec 31, 2021 | $93.76M | – |
| Q3 FY2021 | Sep 30, 2021 | -$39.31M | – |
| Q2 FY2021 | Jun 30, 2021 | $10.84M | – |
| Q1 FY2021 | Mar 31, 2021 | -$14.03M | – |
| Q4 FY2020 | Dec 31, 2020 | -$12.17M | – |
| Q3 FY2020 | Sep 30, 2020 | -$15.28M | – |
| Q2 FY2020 | Jun 30, 2020 | -$36.16M | – |
| Q1 FY2020 | Mar 31, 2020 | -$7.40M | -109.3% |
| Q4 FY2019 | Dec 31, 2019 | -$29.35M | – |
| Q3 FY2019 | Sep 30, 2019 | -$13.21M | -1000.2% |
| Q2 FY2019 | Jun 30, 2019 | -$18.57M | – |
| Q1 FY2019 | Mar 31, 2019 | $79.24M | – |
| Q4 FY2018 | Dec 31, 2018 | -$20.20M | -440.3% |
| Q3 FY2018 | Sep 30, 2018 | $1.47M | – |
| Q2 FY2018 | Jun 30, 2018 | -$27.47M | – |
| Q1 FY2018 | Mar 31, 2018 | -$29.92M | – |
| Q4 FY2017 | Dec 31, 2017 | $5.94M | – |
| Q3 FY2017 | Sep 30, 2017 | -$23.02M | – |
| Q2 FY2017 | Jun 30, 2017 | -$8.06M | – |
| Q1 FY2017 | Mar 31, 2017 | -$15.95M | – |
| Q4 FY2016 | Dec 31, 2016 | -$9.56M | – |
| Q3 FY2016 | Sep 30, 2016 | -$8.88M | – |
See a number that looks wrong?